Abstract :
Byline: Amal Al Sabahi, Department of Paediatric Hematology and Oncology, The National Oncology Centre; Nawal Al Maskari, Paediatric Infectious Disease, Department of Child Health; Ibrahim Al Busaidi, Department of Child Health, Nizwa Hospital, Nizwa, Oman; Khalil A. Albiroty, Department of Paediatric Hematology and Oncology, The National Oncology Centre; Ahmed Alkhamisy, Paediatric Intensive Care Unit, Department of Child Health, The Royal Hospital, Muscat; Karima Al Hinai, Department of Paediatric Hematology and Oncology, The National Oncology Centre; Mohammed Al Hinai, Department of Paediatric Hematology and Oncology, The National Oncology Centre; Nawal Al Mashaikhi, Department of Paediatric Hematology and Oncology, The National Oncology Centre; Jalila Alkendi, Department of Paediatric Hematology and Oncology, The National Oncology Centre Abstract BACKGROUND: In March 2020, WHO announced Coronavirus Disease 2019 (COVID-19) outbreak a global pandemic. During this pandemic, patients with sickle cell disease (SCD) have been placed in the "high-risk" category of the population. Although there are numerous publications describing COVID-19 in adult patients, pediatric data are still limited. OBSERVATION: Herein, we report case series of 5 sickle cell disease Omani children who got infected with COVID-19; illustrating their different ways of presentation, management and highlighting the outcomes. CONCLUSION: Although SCD patients are considered as a high-risk group, all of the observed patients, and whose cases are reported here, have recovered. A large scale of SCD cases should be studied to reach more conclusive results.